Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2003-4-1
pubmed:abstractText
Cardiac hypertrophy, or an increase in heart size, is an important risk factor for cardiac morbidity and mortality. The mammalian target of rapamycin (mTOR) is a component of the insulin-phosphoinositide 3-kinase pathway, which is known to play a critical role in the determination of cell, organ, and body size.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Glycogen Synthase Kinase 3, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 8, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6, http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6 Kinases, 70-kDa, http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus, http://linkedlifedata.com/resource/pubmed/chemical/TOR Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/glycogen synthase kinase 3 beta, http://linkedlifedata.com/resource/pubmed/chemical/mTOR protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/ribosomal protein S6 kinase, 70kD...
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
107
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1664-70
pubmed:dateRevised
2011-11-2
pubmed:meshHeading
pubmed-meshheading:12668503-Animals, pubmed-meshheading:12668503-Aorta, pubmed-meshheading:12668503-Cardiomegaly, pubmed-meshheading:12668503-Constriction, pubmed-meshheading:12668503-Fetus, pubmed-meshheading:12668503-Gene Expression Regulation, pubmed-meshheading:12668503-Glycogen Synthase Kinase 3, pubmed-meshheading:12668503-Heart, pubmed-meshheading:12668503-Hemodynamics, pubmed-meshheading:12668503-Male, pubmed-meshheading:12668503-Mice, pubmed-meshheading:12668503-Mitogen-Activated Protein Kinase 8, pubmed-meshheading:12668503-Mitogen-Activated Protein Kinases, pubmed-meshheading:12668503-Myocardium, pubmed-meshheading:12668503-Myocytes, Cardiac, pubmed-meshheading:12668503-Organ Size, pubmed-meshheading:12668503-Phosphorylation, pubmed-meshheading:12668503-Protein Kinase Inhibitors, pubmed-meshheading:12668503-Protein Kinases, pubmed-meshheading:12668503-RNA, Messenger, pubmed-meshheading:12668503-Ribosomal Protein S6, pubmed-meshheading:12668503-Ribosomal Protein S6 Kinases, 70-kDa, pubmed-meshheading:12668503-Sirolimus, pubmed-meshheading:12668503-TOR Serine-Threonine Kinases
pubmed:year
2003
pubmed:articleTitle
Rapamycin attenuates load-induced cardiac hypertrophy in mice.
pubmed:affiliation
Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, Mass 02215, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't